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Structure of CD94 Reveals
a Novel C-Type Lectin Fold: Implications
for the NK Cell±Associated CD94/NKG2 Receptors
inhibitory motifs (ITIMs), while activating receptors pos-
sess a positively charged residue within the transmem-
brane region that interacts with an immunoreceptor tyro-
sine-based activation motif (ITAM)-containing adaptor
molecule such as DAP12 (Lanier et al., 1998a, 1998b;
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The CD94/NKG2 receptors are a family of heterodi-National Institute of Allergy and Infectious Diseases
meric proteins expressed on the surface of NK cells,National Institutes of Health
with each comprised of an invariant CD94 polypeptide12441 Parklawn Drive
disulfide linked to either NKG2A/B, -C, or -E (AramburoRockville, Maryland 20852
et al., 1990; Lazetic et al., 1996; Brooks et al., 1997;
Carretero et al., 1997; Cantoni et al., 1998). NKG2A and
-B are inhibitory and NKG2C and -E are activating. Re-Summary
cently, the ligand for the CD94/NKG2A/B and -C recep-
tors has been identified as the nonclassical class IbThe crystal structure of the extracellular domain of
human leukocyte antigen (HLA)-E (Borrego et al., 1998;CD94, a component of the CD94/NKG2 NK cell recep-
Braud et al., 1998; Lee et al., 1998), which presentstor, has been determined to 2.6 AÊ resolution, revealing
peptides derived from the signal sequences of manya unique variation of the C-type lectin fold. In this
HLA-A, -B, -C and -G alleles (Braud et al., 1997a). Cellvariation, the second a helix, corresponding to resi-
surface HLA-E expression depends on the presence ofdues 102±112, is replaced by a loop, the putative car-
these signal peptides, thus allowing for a rather elegantbohydrate-binding site is significantly altered, and the
NK cell immunosurveillance strategy where nonpoly-Ca21-binding site appears nonfunctional. This struc-
morphic CD94/NKG2 receptors are capable of monitor-ture may serve as a prototype for other NK cell re-
ing the expression of the polymorphic class I MHC mole-ceptors such as Ly-49, NKR-P1, and CD69. The CD94
cules through interaction with HLA-E (Braud et al.,dimer observed in the crystal has an extensive hydro-
1997a, 1997b).phobic interface that stabilizes the loop conformation
Historically, C-type lectins have been defined as aof residues 102±112. The formation of this dimer re-
superfamily of homologous modular carbohydrate rec-
veals a putative ligand-binding region for HLA-E and
ognition domains (CRD) of 115±130 residues that bind
suggests how NKG2 interacts with CD94.
carbohydrate moieties in a Ca21-dependent manner and
contain either two or three invariant disulfide bonds (short-
Introduction and long-form C-type lectins, respectively) (Drickamer,
1993; Day, 1994). However, not all proteins character-
As an integral component of the innate immune system, ized in this superfamily have been shown to bind carbo-
NK cells are lymphocytes that participate in cytokine hydrate (Day, 1994). The 200 or more protein sequences
production and cytotoxicity. NK cell activity is tightly now known to contain C-type lectin domains are formally
regulated by several families of receptors that recognize classified into seven different categories according to
class I major histocompatability complex (MHC) mole- sequence homology and/or the overall modular archi-
cules on the surface of target cells (reviewed by Long tecture of the protein (Drickamer, 1993). CD94/NKG2
and Wagtmann, 1997; Moretta and Moretta, 1997; La- and other cell surface receptors such as Ly-49, NKR-
nier, 1998). These receptors effectively enable NK cells P1, and CD69 form a unique category of C-type lectins,
to discriminate between healthy cells and pathogen- known as group V, which are distinctly different in se-
infected cells or tumor cells by monitoring the levels of quence from the other categories. These dimeric recep-
MHC class I molecules. Downregulation of MHC class tors lack most of the conserved Ca21-binding residues
I molecule expression through infections, tumorgenesis, observed in the majority of other sequences (Drickamer,
or other cellular incursions may render cells susceptible 1993), and it has been suggested that they be renamed
to attack by NK cells (Ljunggren and KaÈ rre, 1990; Pende as a new family, the C-type lectin-like NK receptor do-
et al., 1998). Structurally, these class I±recognizing re- mains (NKD) (Weis et al., 1998).
ceptors belong to either the immunoglobulin (Ig) super- In contrast to the KIR receptors whose functional
family (e.g., the killer cell inhibitory receptor [KIR] family) binding region has been mapped by mutagenesis and
as type I transmembrane glycoproteins with one or more is supported by two crystal structures (Fan et al., 1997;
extracellular Ig domains or to the C-type lectin super- unpublished data), very little is known regarding the
family (e.g., CD94/NKG2 or Ly49) as dimeric type II trans- structure of the NKD receptors, how they recognize their
membrane glycoproteins with a C-type lectin domain on ligands, or how they dimerize. Moreover, there are no
the C-terminal of each chain. Both superfamilies include known structures of protein-binding dimeric cell surface
activating and inhibitory receptors. Inhibitory receptors receptors in the C-type lectin superfamily available to
contain cytoplasmic immunoreceptor tyrosine-based date. In an attempt to understand how this fold functions
as a receptor to recognize protein ligands, we have
determined the crystal structure of the ligand-binding³ To whom correspondence should be addressed (e-mail: sun@
magenta.niaid.nih.gov). domain of CD94.
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Table 1. Data Collection, Phasing, and Refinement Statistics
Unique Completeness Sites Phasing
Data Set dmin (AÊ ) Reflections Redundency (%) Rsymc (N) Power d
Nativea 2.6 6450 4.8 94.5 6.3 Ð Ð
AuCl3b 3.2 3626 6.1 99.1 7.2 3 2.81
K2PtCl4b 3.4 3109 4.6 98.8 9.2 10 0.95
UO2 (oAc)b 4.0 1452 1.9 74.7 8.9 2 0.56
IrCl6b 3.3 3331 5.9 98.5 7.0 6 0.98
Refinement (8.0±2.6 AÊ )
Rms Deviations
Non-H Solvent
Rcryst Rfreee Atoms Sites Bonds (AÊ ) Angles (8)
22.0 32.3 1036 39 0.009 1.6
a Data collected at the X9B beamline of the National Synchrotron Light Source (NSLS), Brookhaven, NY.
b Data collected on an R-AXIS IIC system (Molecular Structure Corporation).
c Rsym 5 100 3 S|Ih 2 ,Ih.|/SIh, where ,Ih. is the mean intensity of multiple measurements of symmetry related reflections.
d Phasing power is the rms value of Fh divided by the rms lack-of-closure error. The overall figure of merit is 0.70±3.2 AÊ .
e Rfree was calculated using 5% of the data.
Results and Discussion (Leu105, Phe107, Met108, and Tyr115) packing into a
hydrophobic core, two salt bridges (Glu104±Lys175 and
The Overall Structure of CD94 Asp106±Arg69), and several hydrogen bonds (Figure
The extracellular ligand-binding domain of human CD94, 2A). As a result of this helix-to-loop transformation, a
corresponding to residues 34±179, was expressed in a neighboring hairpin loop (loop 6, residues 156±159) be-
bacterial expression system and refolded in vitro. The tween b strands 5 and 6 moves into close contact with
crystal structure of this fragment was determined to 2.6 loop 3, making specific hydrogen bonds through the
AÊ resolution by multiple isomorphous replacement and side chains of Asn156 and Asn158 and nonpolar interac-
anomalous scattering (MIRAS) using four heavy atom tions through Pro157.
derivatives (Table 1). The 2Fobs2Fcalc electron density for The putative Ca21-dependent carbohydrate-binding
CD94 forms a continuous map with no breaks, with the loop (loop 5, residues 142±152) is 2±5 residues shorter
exception of N-terminal residues from the neck region. in CD94 compared to other C-type lectins of known
The final model comprises residues Cys59 to Ile179 (the structure and displays a markedly different conforma-
numbering is consistent with the mature protein se- tion as well as a different sequence (Figure 2B). Among
quence). The molecule, with overall dimensions of ap- the five consensus Ca21 coordinating residues, only one
proximately 42 3 37 3 33 AÊ , consists of a three stranded is preserved in CD94 (Asp163, in b strand 6). Although
antiparallel b sheet (strands 1, 2, and 7), a four stranded residues Asn148 and Asn151 are in a position to be
antiparallel b sheet (strands 4, 3, 5, and 6) and an a potential Ca21 ligands, both side chains point away from
helix after strand 2 (Figures 1A and 1B). There are four the Ca21-binding site (Figure 2B). In contrast, the crystal
intrachain disulfide bonds in CD94, three of which are structures of the known Ca21-dependent lectins and
the characteristic invariant disulfides (Cys61±Cys72, sequence alignments reveal a rather conserved Ca21-
Cys89±Cys174, and Cys152±Cys166) found in long-form binding site (referred to as Ca21 site 2 in rat mannose-
C-type lectins (Day, 1994). The fourth disulfide, Cys59± binding protein [MBP]-A) with four or five protein side
Cys70, which forms a looped structure with N-terminal
chains coordinating the calcium ion. Moreover, even the
b strands, is unique to the structure of CD94. The only
structure of human lithostathine (Brookhaven PDB entry
extracellular cysteine not involved in intrachain disulfide
1LIT), which has no conserved Ca21-binding residues,pairing, Cys58, is expected to pair with the equivalent
has a loop 5 conformation very similar to those of thecysteine of NKG2 (e.g., Cys116 in NKG2A) to form the
Ca21-dependent C-type lectins. Despite the fact thatinterchain disulfide in the CD94/NKG2 heterodimer.
CD94 was crystallized in presence of 100 mM Ca21, noUnlike the canonical C-type lectin fold, CD94 lacks
visible electron density can be attributed to bound Ca21one of two major a helices present in all other C-type
in this vicinity. This is consistent with studies that showlectin structures known to date. Specifically, the region
the binding of CD94/NKG2A/B and -C to HLA-E to befrom residues 102 to 112 (within loop 3), corresponding
carbohydrate independent (Braud et al., 1998).to the second helix of the consensus C-type lectin fold,
Apart from the missing helix and the conformation ofadopts a loop conformation in CD94 (Figures 2A and
the Ca21-binding loop, the rest of the CD94 structure is2C). The loss of this helix is unexpected considering
quite similar to the classical C-type lectin fold eventhe strong sequence similarity for this region with other
though the average sequence identity is only 20% be-lectins of known structure. However, CD94 has the
tween CD94 and C-type lectins of known structure (Fig-shortest sequence in this region, with a 1±7 residue
ure 2C). For example, a superposition of the core regionsdeletion near the C-terminal end of this loop relative to
between the CD94 and rat MBP-A structures, excludingthe other C-type lectins of known structure, which may
the missing helix and loop regions, results in a 1.2 AÊcontribute to the absence of this a helix. The conforma-
tion of loop 3 is stabilized by several nonpolar residues root-mean-square (rms) deviation among 71 a carbons.
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Figure 2. Comparison of Human CD94 and Rat MBP-A
CD94 is magenta and MBP-A (Brookhaven PDB entry 1RTM) is blue.
(A) Loops 3 and 6 in CD94. Side chains displayed are those that
play a prominent role in stabilizing loop 3. Acidic residues are red,
Figure 1. The Structure of Human CD94 basic residues are blue, and neutral residues are tan. Two salt
bridges are designated by dotted lines.(A) Ribbon diagram of the structure of CD94. b strands are shown
(B) Superposition of the Ca21-binding site of rat MBP-A with thein purple and are numbered according to their order in the sequence;
same region in the human CD94 structure (loop 5 and b strandthe a helix is shown in green. The disulfide bonds are represented
6). Ca21-binding residues from MBP-A and potential Ca21-bindingby yellow ball-and-stick models and labeled. Secondary structure
residues in CD94 are represented by ball-and-stick models.assignments based on the program DSSP (Kabsch and Sander,
(C) Superimposed and separated ribbon diagrams of the C-type1983) are as follows: b strands 1±7 corresponding to residues 66±68,
lectin domains from CD94 (left) and MBP-A (right).71±75, 115±122, 127±129, 151±155, 161±165, and 171±176; a helix
1 corresponding to residues 82±91.
(B) Stereo view of an a carbon trace of CD94. Every tenth a carbon
is colored red and labeled. Val66, Tyr68, Ile75, Phe107, and Met108) (Figure 3) sur-
rounded by hydrophilic residues with a buried surface
area of 1204 AÊ 2, which is comparable to the interface
area between the Va and Vb domains of the ab T cellCD94 Exists as a Dimer with Extensive
Interface Area receptor (TCR) (Garboczi et al., 1996; Garcia et al., 1996).
It is noteworthy that a significant part of the interfaceFunctionally, CD94 exists in a heterodimeric disulfide-
linked complex with NKG2A/B, -C, or -E (Aramburo et observed in this dimer involves loop 3, where the helix-
to-loop transformation has occurred in CD94, sug-al., 1990; Lazetic et al., 1996; Brooks et al., 1997; Carre-
tero et al., 1997; Cantoni et al., 1998). However, homodi- gesting that this loop conformation may be partly stabi-
lized through hydrophobic interactions across the dimermeric CD94 has been found on the surface of certain
transfected cell lines in which the expression of NKG2 interface.
Indeed, when loop 3 is modeled as an a helix into theis absent (Carretero et al., 1997; Lanier, 1998). Consis-
tent with these observations, results from gel filtration CD94 dimer using the structural superposition of rat
MBP-A and CD94 as a guide, it results in the C-terminaland gel electrophoresis indicate that the extracellular
portion of CD94 forms noncovalent dimers (data not ends of the modeled helices packing loosely against
each other at an angle of approximately 1458, creatingshown). A 2-fold related crystallographic dimer was ob-
served in CD94 crystals in which two monomers hydro- steric hindrance with the existing loop 6. In addition,
this results in a much smaller dimer interface, leavinggen bond through their respective first b strands, creat-
ing an extended six-stranded antiparallel b sheet (Figure several nonpolar side chains, including Val66, Tyr68,
Ile75, Leu105 and Phe107 of CD94, solvent exposed. It3). The interface of this elongated dimer is relatively
flat and contains a central hydrophobic region (residues thus appears that adopting a loop instead of a helical
Immunity
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dimers have orientations significantly different from that
observed in CD94.
The Dimer of CD94 Provides an Intriguing
Model for the CD94/NKG2 Heterodimer
The primary sequences of NKG2 molecules A/B, C, and
E share 27%±32% identity with CD94 within the C-type
lectin domain with minimal insertions or deletions, sug-
gesting a strong structural similarity between CD94 and
the NKG2 molecules (Figure 4). The dimerization of CD94
brings the two N-terminal a carbons to within 7.4 AÊ of
each other, which is consistent with having a disulfide
bond between the two chains of the receptor. Modeling
based on the CD94 homodimer structure reveals some
interesting features about the putative CD94/NKG2 het-
erodimer interface. Of the five hydrophobic core resi-
dues at the dimer interface of CD94, three are completely
conserved in the NKG2 sequences, and two are replaced
with other nonpolar residues. This distinctly hydropho-
bic patch forms the largest contiguous nonpolar surface
on both the CD94 monomer and the model of NKG2.
While the CD94 homodimer has no interchain salt
bridges, there are two potential regions of charge com-
plementarity across the modeled CD94/NKG2 interface:
one is between Asp106 of CD94 and Lys135 of NKG2A
Figure 3. Ribbon Models Showing Two Views of the CD94 Dimer
and the other is between Arg69 of CD94 and Glu122
Each monomer is colored a different shade of green. Regions that of NKG2A. Lys135 and Glu122 are each conserved
have low sequence identity with the NKG2 sequences are colored
throughout NKG2A/B, -C, and -E sequences, but arepurple. The top view is rotated 908 from the bottom view along the
replaced by Ser and Lys, respectively, in CD94, creat-horizontal axis. In the bottom view, residues in the hydrophobic
core of the dimer interface (V66, Y68, I75, F107, and M108) are ing an unfavorable Arg69±Lys64 interaction across the
represented by ball-and-stick models. These residues are colored CD94/CD94 interface. This may help to explain the favor-
red in one monomer and yellow in the other. able interaction between CD94 and NKG2 compared to
CD94 homodimerization.
In order to form a heterodimer similar to the CD94
conformation for residues 102±112 of CD94 helps to homodimer, NKG2 would be expected to have the same
stabilize the dimer interface by burying hydrophobic helix-to-loop transformation in the region between a
side chains and increasing the dimer interface contact helix 1 and b strand 3 as observed in CD94. Indeed, the
area. sequence of loop 3 is remarkably homologous between
The dimer arrangement observed in CD94 is unique CD94 and NKG2, with no insertions or deletions (Figure
among known structures of C-type lectin domains such 4), and the NKG2 sequence is easily accommodated in
as rat MBP-A and -C and human MBP, tetranectin, the CD94 loop structure. In particular, among residues
E-selectin and lithostathine, sea raven type II antifreeze forming the hydrophobic core of loop 3, Phe107 is con-
protein, and the two subunits of heterodimeric snake served in NKG2 sequences, Leu105 is replaced by me-
venom coagulation factors IX/X-binding protein (Weis thionine or isoleucine, and Met108 is replaced by a con-
et al., 1991; Graves et al., 1994; Sheriff et al., 1994; served leucine.
Bertrand et al., 1996; Ng et al., 1996; Mizuno et al., 1997; A fourth member of the NKG2 family, NKG2D, is signifi-
Nielsen et al., 1997; Gronwald et al., 1998). Rat and cantly divergent. Although all nine NKG2 cysteines are
human MBP and human tetranectin each form trimers conserved, NKG2D shares only 21% sequence homol-
that are held together by an N-terminal triple a helical ogy with other NKG2 members, compared to 94%±95%
coiled coil with limited contact between neighboring sequence homology observed between the extracellular
C-type lectin domains. The snake venom coagulation domains of NKG2A/B, -C, and -E (Houchins et al., 1991;
factors IX/X-binding protein is a disulfide-linked het- Ho et al., 1998). Furthermore, no CD94/NKG2D hetero-
erodimer of two C-type lectin domains that dimerize dimers have been observed to date. Despite these differ-
through an elongated loop between b strands 2 and 3 ences, all five of the key hydrophobic residues facilitat-
(Mizuno et al., 1997). This dimerization interface is on ing dimerization of CD94 are also nonpolar in NKG2D.
the opposite side of the domain compared to the dimer- However, one other residue (Leu105) that forms part of
ization interface of CD94. The C-type lectin domains the hydrophobic core stabilizing loop 3 in CD94 appears
of lithostathine and E-selectin are not known to form to be a deletion in NKG2D.
dimers. Though not physiological, crystallographic di-
mers are observed in two structures of rat MBP-A and A Putative Binding Site for HLA-E
-C, both of which are lacking their N-terminal trimeriza- The areas of greatest sequence divergence between
tion domains. Albeit similar in buried surface area (1099 human CD94 and NKG2 occur outside the dimer inter-
face in the C-terminal half of the molecule, forming aAÊ 2 and 1009 AÊ 2 for MBP-A and -C, respectively), these
Crystal Structure of Human CD94
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Figure 4. Sequence Alignment between Hu-
man CD94 and Human NKG2A/B, -C, and -E
The N-terminal cytoplasmic regions of
NKG2A/B, -C, and -E that have no counter-
part in CD94 are not shown. Swissprot acces-
sion numbers identify each sequence. Note
that NKG2A and -B are likely different splic-
ing products of the same gene (Houchins et
al., 1991). The alignment was created using
PILEUP from the GCG package (Wisconsin
package version 9.0, Genetics computer group
(GCG), Madison, Wisconsin) and edited by
hand. Residues conserved with the CD94 se-
quence are highlighted in yellow. Regions of
low sequence homology are highlighted by a
blue hash. The secondary structure of CD94
is displayed above the alignment in blue. b
strands and a helices in the CD94 structure
are represented by arrows and cylinders, re-
spectively.
contiguous surface at one end of the CD94 molecule than CD94, with six basic residues and four acidic resi-
dues (Figure 5).(Figures 3 and 4). These variable regions, which encom-
pass 2558 AÊ 2 of solvent-accessible surface area per Loop 5 of CD94, corresponding to the Ca21-binding
loop of the C-type lectin fold, is the longest of the puta-monomer, abut each other to form a flat, uninterrupted
surface across one face of the molecule opposite from tive HLA-E-binding loops. It is also the loop most differ-
ent in sequence between CD94 and NKG2. In NKG2A,the N- and C-termini. Based on this structure and se-
quence alignments, we postulate that the putative li- loop 5 is two residues shorter and contains seven out
of the ten charged residues observed on the putativegand-binding site resides within this variable region in-
cluding residues 110±115, 120±124, 137±142, 144±150, binding surface of NKG2 (compared to two out of the ten
charged residues in the putative binding site of CD94).159±165, and 167±171 of human CD94 and the equiva-
lent residues of human NKG2. The relative flatness of Since loop 5 is highly conserved between NKG2A/B,
-C and -E, it may play a pivotal role in HLA-E binding.this putative binding region superficially resembles that
of the MHC-binding surface observed on the ab TCR
(Garboczi et al., 1996; Garcia et al., 1996), in contrast Implications for the Structure of Other NK Cell
Receptors of the C-type Lectin Superfamilyto the well-carved binding surfaces of the human growth
hormone receptor (De Vos et al., 1992). The variable The crystal structure of CD94 provides a structural
model for other group V C-type lectins, such as murineregion of CD94 has an overall net negative charge, with
seven acidic residues and only three basic residues Ly-49A to -H, murine NKR-P1-2, -34, and 240, and both
human and murine CD69, which are all distinctly differ-(Figure 5). In contrast, the corresponding regions of the
NKG2A sequence is considerably more positively charged ent in sequence from other C-type lectins (references
Figure 5. Model of the CD94/NKG2A Hetero-
dimer
NKG2A is on the left side of the dimer rep-
resented by a light-green ribbon model
and CD94 is on the right side represented
by a dark-green ribbon model. Each of the
charged residues within the putative HLA-E-
binding surface is represented by a colored
ball at the a carbon position and labeled ac-
cording to the one-letter amino acid code.
Red balls represent acidic residues and dark-
blue balls represent basic residues.
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for these sequences are found in Weis et al., 1998). The
question remains as to whether or not these receptors
dimerize in the same manner as CD94. The dimerization
of CD94 is facilitated by a number of key hydrophobic
residues (including Val66, Tyr68, Ile75, Leu105, Phe107,
and Met108), by the unique conformation of loop 3, and
by several hydrogen bonds. In both the Ly-49 and CD69
receptor families, all six of the nonpolar residues listed
above are either conserved or replaced with other non-
polar residues, consistent with CD94 dimer formation.
This is in contrast to the sequences of the known C-type
lectin structures, which do not display a consistent se-
quence conservation of nonpolar residues at these six
positions. In the murine NKR-P1 sequences, all but one
of these residues (corresponding to position 68 in CD94)
are nonpolar. The regions of the Ly-49, NKR-P1, and
CD69 sequences corresponding to the dimer interface
portion of loop 3, a key determinant in CD94 dimer for-
mation, are rather conserved. However, the C-terminal
region of this loop is 2±4 residues longer than in CD94
and displays considerable variability relative to CD94,
NKG2, and to each other. Since the C-terminal end of
loop 3 in CD94 and NKG2 may be involved in ligand
binding, it is quite possible that these variable residues
are also part of a binding loop.
Conclusions
Until now, information regarding the molecular details
of the structure of the CD94/NKG2 family of receptors
and how they interact with HLA-E (Figure 6) has re-
mained elusive, despite the recent determination of the
three-dimensional structure of HLA-E (O'Callaghan et
al., 1998). The crystal structure of CD94 provides us with Figure 6. Hypothetical Model of the CD94/NKG2 Heterodimer and
Its Ligand HLA-E on an NK Cell and a Target Cell, Respectivelynew insight regarding these questions. The structure
reveals not only a novel variation of the canonical C-type The CD94/NKG2 heterodimer is represented by the CD94 homodi-
mer. HLA-E coordinates were provided by C. O'Callaghan and J.lectin fold, but also a potential model for the CD94/NKG2
Tormo. For greater clarity, the peptide bound to HLA-E is not shown.heterodimeric receptor. The sequences of NKG2A/B,
-C, and -E each appear compatible with both the helix-
20% glycerol in precipitation solution (increasing glycerol concen-to-loop transformation and the dimer interface. In addi-
tration by 5% every 30 min).tion, several key residues involved in CD94 dimerization
are conserved in the sequences of Ly-49, NKR-P1, and
Structure Determination
CD69, suggesting the possibility that these receptors All data were collected at 21808C. Diffraction data were processed
dimerize in a similar manner. We also propose a putative using DENZO and SCALEPACK (Otwinowski and Minor, 1997) and
scaled with CCP4 programs (CCP4, 1995). The major sites for theHLA-E-binding surface for CD94/NKG2 in which the
AuCl3 derivatives were solved by inspection of difference PattersonNKG2 portion is predominately basic and the CD94 half
maps. The other three derivatives were solved by difference Fourieris more acidic. However, the critical residues involved
methods. MLPHARE (CCP4, 1995) was used to generate and refinein ligand recognition remain to be proven by either analy-
MIRAS phases from four heavy metal derivatives (Table 1). After
sis of mutations or the determination of structures of subsequent phase improvement using DM (CCP4, 1995), the elec-
ligand receptor complexes. tron density map was readily interpretable. The model was built
using O (Jones et al., 1991) and its positional and thermal parameters
were refined by conjugate gradients using XPLOR 3.8 (BruÈ nger,Experimental Procedures
1992). Fo's were scaled anisotropically during refinement to match
Fc's, and a bulk solvent correction was applied.Protein Expression and Crystallization
The extracellular fragment of CD94 (residues 34±179) was expressed
as inclusion bodies in E. coli BL21 cells and subsequently refolded Structural Analysis
Superposition of C-type lectin structures was performed using theby stepwise dilution and dialysis. After limited N-terminal proteoly-
sis, crystals were grown by hanging drop vapor diffusion. Aliquots program LSQMAN (Kleywegt and Jones, 1997). Solvent accessible
surface area was determined using SURFACE with a 1.4 AÊ probe(1±5 ml) of CD94 (optical density at 280 nm 5 16) were mixed with
equal amounts of precipitation solution containing 15% PEG 8000, (CCP4, 1995). Modeling of the CD94/NKG2 heterodimer structure
was performed by overlaying the sequence of NKG2A onto one100 mM CaCl2, and 50 mM HEPES (pH 7.5) and suspended over a
well containing 1.0 ml of precipitation solution. Elongated CD94 monomer of the CD94 homodimer structure according to the align-
ment in Figure 4. The program O (Jones et al., 1991) was used tocrystals grew to dimensions of 0.5 3 0.15 3 0.10 mm within 2 weeks.
The crystals belong to the hexagonal spacegroup P6522 with cell mutate side chains and to view the model. All figures except Figure
4 were produced with MOLSCRIPT (Kraulis, 1991) and RASTER3Ddimensions of a 5 b 5 91.7 AÊ , c 5 84.2 AÊ and contain one molecule
per asymmetric unit. Crystals were cryofrozen by step transfer to (Merrit and Murphy, 1994).
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